| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 04/02/2009 | WO2009042727A1 Immediate early gene arc interacts with endocytic machinery and regulates the trafficking and function of presenilin |
| 04/02/2009 | WO2009040363A1 Glycoproteins and glycosylated cells and a method for the preparation of the same |
| 04/02/2009 | WO2009010271A3 Chromatographic methods |
| 04/02/2009 | WO2005054433A3 A novel “cleave-n-read” system for protease activity assay and methods of use thereof |
| 04/02/2009 | WO2005044974A3 Cell death-related nucleases and their uses |
| 04/02/2009 | WO2005002416A3 Predictors of renal disease |
| 04/02/2009 | WO2004069859A3 Restoring function to gonadotropin releasing hormone receptor mutants |
| 04/02/2009 | WO2003087125A3 A novel g protein-coupled purinergic receptor, gave 17 |
| 04/02/2009 | US20090088559 Method for preparing modified polypeptides |
| 04/02/2009 | US20090088554 Hdm2-inhibitor complexes and uses thereof |
| 04/02/2009 | US20090088553 Bis-Sulfhydryl Macrocyclization Systems |
| 04/02/2009 | US20090088466 Opioid receptor ligands |
| 04/02/2009 | US20090087916 Assay method for identifying drug candidate |
| 04/02/2009 | US20090087905 VEGF-D polynucleotides and methods of use |
| 04/02/2009 | US20090087622 Directed Assembly of Carbon Nanotubes and Nanoparticles Using Nanotemplates With Nanotrenches |
| 04/02/2009 | US20090087382 Contrast agents and methods for preparing contrast agents |
| 04/02/2009 | CA2700587A1 Glycoproteins and glycosylated cells and a method for the preparation of the same |
| 04/01/2009 | EP2042511A1 Method for pre-treatment of serum for analysis of sugar chain |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2041155A1 Virus removal by nanofiltration |
| 04/01/2009 | EP2041154A2 Refolding of recombinant proteins |
| 04/01/2009 | EP1773866A4 Use of metal complexes |
| 04/01/2009 | EP1721161A4 Multi-polymer-coated magnetic nanoclusters |
| 04/01/2009 | EP1455592B1 Enhanced oil seed protein recovery |
| 04/01/2009 | EP0888386B2 Stable, virus-safe factor VIII-complex concentrate |
| 04/01/2009 | CN101401002A Nanoporous substrates for analytical methods |
| 04/01/2009 | CN101397581A Method for extracting fishskin collagen polypeptide from fish wastes |
| 04/01/2009 | CN101397339A Method for removing/inactivating virus in glucoprotein |
| 03/31/2009 | US7511155 Reagents and a method for saturation labelling of proteins |
| 03/31/2009 | US7511095 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith |
| 03/31/2009 | US7511094 2-methylbutyraldehyde diethyl acetal end capped polyoxyethylene glycol; polyalkylene oxide, polyivnylpyrrolidone, polyvinyl alcohol, polyoxazoline etc. endcapped with polyetherpolyamine copolymers or oligomers covalently attached to diacetal tetramethylene group |
| 03/31/2009 | US7511039 Thrombin inhibitors; protease inhibition, kinase inhibition, CAAX inhibition, interference with peptides binding to SH2 domains and inhibition of MCH-I and/or MHC II presentation of peptides to T cell receptors |
| 03/31/2009 | US7511018 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 03/31/2009 | US7511015 Ribosylated human neutrophil peptide-1or an ADP-ribosylated human neutrophil peptide-1; modified antimicrobial activity compared to alpha defensin lacking ADP-ribosylated or ribosylated residue; altered chemotaxis of T cells, altered neutrophil recruitment |
| 03/31/2009 | US7510878 Bacillus thuringiensis gene with lepidopteran activity |
| 03/31/2009 | US7510875 Methods for producing purified adenoviral vectors |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | CA2210139C Immunogenic conjugate molecules |
| 03/31/2009 | CA2066204C Cystic fibrosis gene |
| 03/26/2009 | WO2009037592A2 Triazole-based aminoglycoside-peptide conjugates and methods of use |
| 03/26/2009 | WO2008109079A3 High purity peptides |
| 03/26/2009 | WO2005077046A3 A composition and method of treating mastitis |
| 03/26/2009 | WO2005014615A3 Self-assembling peptides incorporating modifications and methods of use thereof |
| 03/26/2009 | WO2004087733A3 Prevention and treatment of alzheimer amyloid deposition |
| 03/26/2009 | WO2003070158A3 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
| 03/26/2009 | US20090082552 Microfluidic protein assay |
| 03/26/2009 | US20090082378 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the b2 adrenergic receptor |
| 03/26/2009 | US20090082275 Ob protein compositions and methods |
| 03/26/2009 | US20090082270 myostatin antagonist protein is substantially serum stable for a period of at least 24 hours; treating individuals with muscle wasting conditions and provides further insight into the regulation of myostatin gene expression; muscular disorders |
| 03/26/2009 | US20090081785 Desiccated Biologics And Methods Of Preparing The Same |
| 03/26/2009 | US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 03/26/2009 | US20090081753 Method for formulating and immobilizing a matrix protein and a matrix protein for use in a sensor |
| 03/26/2009 | US20090081751 Natively glycosylated mammalian biological molecules produced by electromagnetically stimulating living mammalian cells |
| 03/26/2009 | US20090081730 Activatable recombinant neurotoxins |
| 03/26/2009 | US20090081651 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES |
| 03/26/2009 | US20090081638 Immobilisation of Antigenic Carbohydrates to Support Detection of Pathogenic Microorganisms |
| 03/26/2009 | US20090081226 Soluble HLA-E Molecules And Their Use For Diagnosing And Treating Pathologies |
| 03/26/2009 | US20090081181 Isolation of growth and differentiating factors from colostrum |
| 03/26/2009 | US20090081168 Method of forming a peptide-receptor complex with zsig33 |
| 03/26/2009 | US20090081145 Process for forming disulphide bridges |
| 03/26/2009 | CA2700128A1 Method of altering the binding specificity of monoclonal antibodies by oxidation-reduction reactions |
| 03/26/2009 | CA2687689A1 Triazole-based aminoglycoside-peptide conjugates and methods of use |
| 03/25/2009 | EP2039762A2 Nitralases |
| 03/25/2009 | EP2038296A2 Method for the extraction of one or several proteins present in milk |
| 03/25/2009 | EP2038295A1 Pseudo proline dipeptides |
| 03/25/2009 | EP1306383B1 Method of purifying a calcium ion-binding protein |
| 03/25/2009 | CN101395473A Water-soluble conjugates for electrochemical detection |
| 03/25/2009 | CN101392021A Protective antigen composition capable of excitating organism to generate immunity against plague and use thereof |
| 03/25/2009 | CN101392020A Musca domestic pupae natural antimicrobial peptide products and preparation method and use thereof |
| 03/25/2009 | CN101392019A Isolation and purification method of antifreeze protein from ammopiptanthus monogolicus leaf |
| 03/25/2009 | CN101392018A Ammopiptanthus monogolicus protein bidirectional electrophoresis technique |
| 03/25/2009 | CN101392017A Isolation and purification method of main allergic protein of humulus pollen |
| 03/25/2009 | CN100471870C Method for extracting and purifying glycoprotein from oyster shuck |
| 03/25/2009 | CN100471867C Novel method for abstracting vitriol capreomycin |
| 03/25/2009 | CN100471866C Method and apparatus for continuous large-scale radiolabeling of proteins |
| 03/25/2009 | CN100471521C Polypeptides having single covalently bound N-terminal water-soluble polymer |
| 03/24/2009 | US7507794 Isolated soluble corticotropin releasing factor receptor type 2 (sCRFR2) |
| 03/24/2009 | US7507792 MDA-7 proteins and methods of use thereof |
| 03/24/2009 | US7507788 Peptides and methods for cell death regulation |
| 03/24/2009 | US7507404 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 03/24/2009 | CA2316975C Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines |
| 03/24/2009 | CA2223911C The preparation of active peptides |
| 03/24/2009 | CA2176373C Farnesyl derivatives and pharmaceutical compositions containing them |
| 03/19/2009 | WO2009035959A2 Radiofluorination methods |
| 03/19/2009 | WO2009035657A1 Functionalized nanoparticles and method |
| 03/19/2009 | WO2009035617A1 High-pressure refolding of monoclonal antibody aggregates |
| 03/19/2009 | WO2009035347A1 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 03/19/2009 | WO2009034334A1 Pre-staining protocol for a protein sample with a pyrylium dye and respective kit |
| 03/19/2009 | WO2009034204A1 Peptide and protein preservation method |
| 03/19/2009 | WO2009034203A1 Methods for separating recombinant proteins in aqueous two-phase systems |
| 03/19/2009 | WO2009034190A2 Affinity tag |
| 03/19/2009 | WO2009033406A1 Modified recombinant human endostatin and its application |
| 03/19/2009 | WO2009033285A1 Apparatus and method for dehydrating biological materials |
| 03/19/2009 | WO2008124134A3 High-pressure refolding of proteins in the presence of binding partners |
| 03/19/2009 | WO2005074483A3 Genetic markers for skatole metabolism |
| 03/19/2009 | US20090076295 Photocleavable protecting groups |
| 03/19/2009 | US20090076252 Extraction, solubilization, mixing with chilled water, overflowing supernatant; pet foods, animal feeds, cosmetics |
| 03/19/2009 | US20090076244 Beta Helical Peptide Structures Stable in Aqueous and non-Aqueous Media and Methods for preparing same |
| 03/19/2009 | US20090075936 Proteasome inhibitors and methods of using the same |
| 03/19/2009 | US20090075883 Compositions for the treatment of cancer, and methods for testing and using the same |